Back to VP VANGUARD PORTFOLIO MANAGEMENT LLC
RXRX2 quarters
Position history for VPVANGUARD PORTFOLIO MANAGEMENT LLC's holdings in RECURSION PHARMACEUTICALS IN
Yes. Vanguard Portfolio Management holds 31,131,599 shares of RXRX (Recursion Pharmaceuticals in), worth $114.3M, as of its Q2 2026 13F filing. It increased the position by 8,372,499 shares (+36.8%) from Q1 2026. Vanguard Portfolio Management has held RXRX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$114.3M
Current Shares
31.1M
Total Value Change
+$44.4M
Total Shares Change
+8.4M
Quarter-by-Quarter History
Other major holders of RXRX: BAILLIE GIFFORD & CO, ARK Investment Management LLC